Enterococcus faecalis Escapes Complement-Mediated Killing via Recruitment of Complement Factor H.


Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
09 08 2019
Historique:
received: 25 03 2019
accepted: 01 05 2019
pubmed: 7 5 2019
medline: 21 5 2020
entrez: 7 5 2019
Statut: ppublish

Résumé

Enterococcus faecalis is considered to be the most important species of enterococci responsible for blood stream infections in critically ill patients. In blood, the complement system is activated via the classical pathway (CP), the lectin pathway (LP), or the alternative pathway (AP), and it plays a critical role in opsonophagocytosis of bacteria including E faecalis. In a mouse model of enterococcus peritonitis, BALB-C mice were challenged with a high dose of E faecalis 12 hours after intraperitoneal administration of anti-Factor H (FH) antibodies or isotype control. Four hours later, control mice developed higher bacterial burden in blood and organs compared with mice treated with anti-FH antibodies. We demonstrate that complement recognition molecules C1q, CL-11, and murine ficolin-A bind the enterococcus and drive the CP and the LP in human and mouse. We further describe that E faecalis evades the AP by recruitment of FH on its surface. Our results show a strong C3b deposition on E faecalis via both the CP and the LP but not through the AP. These findings indicate that E faecalis avoids the complement phagocytosis by the AP via sequestering complement FH from the host blood.

Sections du résumé

BACKGROUND
Enterococcus faecalis is considered to be the most important species of enterococci responsible for blood stream infections in critically ill patients. In blood, the complement system is activated via the classical pathway (CP), the lectin pathway (LP), or the alternative pathway (AP), and it plays a critical role in opsonophagocytosis of bacteria including E faecalis.
METHODS
In a mouse model of enterococcus peritonitis, BALB-C mice were challenged with a high dose of E faecalis 12 hours after intraperitoneal administration of anti-Factor H (FH) antibodies or isotype control. Four hours later, control mice developed higher bacterial burden in blood and organs compared with mice treated with anti-FH antibodies.
RESULTS
We demonstrate that complement recognition molecules C1q, CL-11, and murine ficolin-A bind the enterococcus and drive the CP and the LP in human and mouse. We further describe that E faecalis evades the AP by recruitment of FH on its surface. Our results show a strong C3b deposition on E faecalis via both the CP and the LP but not through the AP.
CONCLUSIONS
These findings indicate that E faecalis avoids the complement phagocytosis by the AP via sequestering complement FH from the host blood.

Identifiants

pubmed: 31058287
pii: 5485924
doi: 10.1093/infdis/jiz226
doi:

Substances chimiques

Antibodies, Bacterial 0
Lectins 0
Complement C3b 80295-43-8
Complement C4b 80295-50-7
Complement Factor H 80295-65-4
Complement System Proteins 9007-36-7

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1061-1070

Subventions

Organisme : Medical Research Council
ID : G0700859
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0801952
Pays : United Kingdom

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Auteurs

Youssif M Ali (YM)

Department of Microbiology and Immunology, Faculty of Pharmacy, Mansoura University, Egypt.
Department of Veterinary Medicine, School of Biological Sciences, University of Cambridge, United Kingdom.

Robert B Sim (RB)

Department of Pharmacology, Oxford University, United Kingdom.

Wilhelm Schwaeble (W)

Department of Veterinary Medicine, School of Biological Sciences, University of Cambridge, United Kingdom.

Mona I Shaaban (MI)

Department of Microbiology and Immunology, Faculty of Pharmacy, Mansoura University, Egypt.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH